DG DISPATCH - ECCO: New Prostate Treatment Could Save Thousands
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - ECCO: New Prostate Treatment Could Save Thousands

By David Loshak
Special to DG News

VIENNA, AUSTRIA -- September 16, 1999 -- Combining hormonal therapy with standard radiation treatment can successfully combat advanced forms of prostate cancer, according to a new study. Undertaken by the European Organization for Research and Treatment of Cancer (EORTC), the study was reported to the 10th European Conference on Clinical Oncology (ECCO), in Vienna, Austria.

The five-year study involved more than 400 patients with advanced prostate cancer. The patients received a combination of radiotherapy plus 36 monthly injections of goserelin acetate (Zoladex), boosted survival rates to 78 percent, compared with 62 percent from radiotherapy alone.

These findings could transform the way prostate cancer is treated, said Professor Michel Bolla, president of the EORTC radiotherapy group. "This cancer kills thousands of men and there are more cases every year, but this new treatment could save thousands of lives," he added.

Goserelin acetate inhibits the production of the male sex hormone testosterone, which stimulates the growth and spread of prostate cancer cells.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities